Mindray

Mindray Donates to the University of Washington School of Medicine to Kickstart Advanced Emergency Medicine Ultrasonography Fellowship Program

Retrieved on: 
Thursday, December 14, 2023
Anesthesia, Patient, Emergency medicine, University, Corporate communication, Physician, Knowledge, Health, Education, Medical imaging, Mindray, Medicine

MAHWAH, N.J., Dec. 14, 2023 /PRNewswire-PRWeb/ -- Mindray, a global developer of healthcare technologies and solutions for ultrasound, patient monitoring, and anesthesia, announced today its significant financial gift to the University of Washington School of Medicine, which will help initiate the groundbreaking Advanced Emergency Medicine Ultrasonography Fellowship Program. This gift underscores Mindray's unwavering commitment to advancing medical education and fostering the next generation of healthcare professionals.

Key Points: 
  • MAHWAH, N.J., Dec. 14, 2023 /PRNewswire-PRWeb/ -- Mindray, a global developer of healthcare technologies and solutions for ultrasound, patient monitoring, and anesthesia, announced today its significant financial gift to the University of Washington School of Medicine, which will help initiate the groundbreaking Advanced Emergency Medicine Ultrasonography Fellowship Program.
  • The UW School of Medicine's Advanced Emergency Medicine Ultrasonography Fellowship Program's goal is to be the most unique and innovative ultrasound fellowship program in the country.
  • The program aims to equip physicians with advanced skills and knowledge in point of care ultrasound , a critical tool in modern emergency care.
  • "We are appreciative of this gift from Mindray," said Dr. Ross Kessler, program director for the fellowship program at UW Medicine.

Mindray to Host Radiology Experts in Booth at RSNA 2023

Retrieved on: 
Wednesday, November 15, 2023
RSNA, Anesthesia, Mindray, South Hall (UC Berkeley), Use case, Medicine, McCormick Place, FSRU, Radiology, Doctor of Philosophy, Health, Medical imaging, MD

MAHWAH, N.J., Nov. 15, 2023 /PRNewswire-PRWeb/ -- Mindray, a global developer of technologies and solutions for patient monitoring, ultrasound, and anesthesia, today announced that they will attend the Radiological Society of North America Annual Meeting (RSNA) 2023 in Chicago, IL to showcase its innovative solutions in radiology and provide in-booth educational opportunities for attendees. Mindray invites all RSNA attendees to visit Booth 1322 in the South Hall at McCormick Place for live educational sessions led by six renowned clinical speakers and to explore leading-edge ultrasound solutions.

Key Points: 
  • Mindray invites all RSNA attendees to visit Booth 1322 in the South Hall at McCormick Place for live educational sessions led by six renowned clinical speakers and to explore leading-edge ultrasound solutions.
  • Mindray invites all RSNA attendees to visit Booth 1322 in the South Hall at McCormick Place for live educational sessions led by six renowned clinical speakers and to explore leading-edge ultrasound solutions.
  • "Mindray is delighted to host educational sessions in our booth at RSNA this year," said Michelle Carter, Marketing Manager – Radiology Ultrasound, Mindray North America.
  • Mindray invites all RSNA attendees to see how innovative, cost-effective, leading-edge ultrasound solutions can empower Radiology Departments to provide the highest quality of care, now and in the future.

Mindray North America Partners with US Med-Equip for Hospital Rentals of Patient Monitoring, Anesthesia, And Ultrasound Equipment

Retrieved on: 
Thursday, October 26, 2023
Corporation, Mindray, Patient, Anesthesia, Partnership, Hospital, Health care

MAHWAH, N.J., Oct. 26, 2023 /PRNewswire-PRWeb/ -- Mindray North America and US Med-Equip (USME), two leading companies in the medical equipment industry, are helping meet the increasing hospital demand for patient monitoring, anesthesia, and ultrasound solutions under a new partnership.

Key Points: 
  • MAHWAH, N.J., Oct. 26, 2023 /PRNewswire-PRWeb/ -- Mindray North America and US Med-Equip (USME), two leading companies in the medical equipment industry, are helping meet the increasing hospital demand for patient monitoring , anesthesia , and ultrasound solutions under a new partnership.
  • Under this partnership, US Med-Equip will provide rentals to hospitals using Mindray systems so they never have to be without the vital equipment they rely on.
  • "Mindray North America and USME's teams will help hospitals using Mindray's solutions with rentals of monitoring, anesthesia, and ultrasound systems as needed," said Greg Salario, CEO of US Med-Equip.
  • "We'll work together to help clinicians –singly focused on comforting and healing patients— secure Mindray equipment."

Mindray Expands Its Cardiac Biomarker Portfolio with Cutting-Edge hs-cTnI and NT-proBNP Assays, Empowering Enhanced Cardiovascular Diseases Care

Retrieved on: 
Monday, October 23, 2023
URL, Mindray, N-terminal prohormone of brain natriuretic peptide, Myocardial injury after non-cardiac surgery, Biomarker, Antigen, Acute coronary syndrome, HyTest Ltd, Research, Antibody, ACS, CVD, AACC, CV, Lod, 99th Infantry Division (United States), Diagnosis, Death, Heart failure, SZSE, Medical device

The additions have enhanced Mindray's diverse portfolio of cardiac biomarkers for cardiovascular diseases (CVDs) diagnosis and management.

Key Points: 
  • The additions have enhanced Mindray's diverse portfolio of cardiac biomarkers for cardiovascular diseases (CVDs) diagnosis and management.
  • While CVDs are the leading cause of death worldwide, early detection is key in saving lives.
  • The two assays are the collaborative effort of Mindray and HyTest, a Mindray company and a prominent global provider of antibodies and antigens.
  • HyTest, renowned for its cardiac biomarker expertise, had its cardiac troponin complex material selected as the international troponin standard by AACC in 2004.

Mindray Expands Its Cardiac Biomarker Portfolio with Cutting-Edge hs-cTnI and NT-proBNP Assays, Empowering Enhanced Cardiovascular Diseases Care

Retrieved on: 
Monday, October 23, 2023
URL, Mindray, N-terminal prohormone of brain natriuretic peptide, Myocardial injury after non-cardiac surgery, Biomarker, Antigen, Acute coronary syndrome, HyTest Ltd, Research, Antibody, ACS, CVD, AACC, CV, Lod, 99th Infantry Division (United States), Diagnosis, Death, Heart failure, SZSE, Medical device

The additions have enhanced Mindray's diverse portfolio of cardiac biomarkers for cardiovascular diseases (CVDs) diagnosis and management.

Key Points: 
  • The additions have enhanced Mindray's diverse portfolio of cardiac biomarkers for cardiovascular diseases (CVDs) diagnosis and management.
  • While CVDs are the leading cause of death worldwide, early detection is key in saving lives.
  • The two assays are the collaborative effort of Mindray and HyTest, a Mindray company and a prominent global provider of antibodies and antigens.
  • HyTest, renowned for its cardiac biomarker expertise, had its cardiac troponin complex material selected as the international troponin standard by AACC in 2004.

Mindray's Collaboration with Edwards Lifesciences Marks the First Integration of The FloTrac™ Sensor for Multiparameter Bedside Monitoring

Retrieved on: 
Thursday, October 12, 2023
Pressure, Nursing care plan, Perfusion, Mindray, Health, Patient safety, Anesthesia, Edwards Lifesciences, Patient, Medical device, Pharmaceutical industry

MAHWAH, N.J., Oct. 12, 2023 /PRNewswire/ -- Mindray, a global leader and developer of healthcare solutions and technologies in ultrasound, patient monitoring, and anesthesia, announced a new milestone in their cooperative agreement with Edwards Lifesciences, a global leader in medical innovations for structural heart disease and critical care monitoring. This milestone provides a solution that makes Mindray's BeneVision N-Series the first patient monitoring system to integrate with Edwards FloTrac™ sensor for hemodynamic monitoring in the North American market, following their launch in China in 2022. 

Key Points: 
  • This milestone provides a solution that makes Mindray's BeneVision N-Series the first patient monitoring system to integrate with Edwards FloTrac™ sensor for hemodynamic monitoring in the North American market, following their launch in China in 2022.
  • Mindray's BeneVision N-Series is the first patient monitoring platform to integrate Edwards' FloTrac™ sensor.
  • The continuous monitoring of pressure and flow parameters is essential for managing hemodynamically unstable patients to guide appropriate treatment.
  • This collaboration is a testament to the companies' commitment to improving clinical decision-making, productivity, and ultimately advancing patient care.

Mindray to Reveal First of its Kind Wireless Handheld Ultrasound System Live at ACEP23 Scientific Assembly

Retrieved on: 
Friday, October 6, 2023
Assembly, Innovation system, ZST, Atmosphere of Earth, Emergency department, ACEP, American College, POCUS, Mindray, Risk, Emergency, Convention center, Puerto Rico Convention Center, Health, Emergency medicine, Marketing, TE, Anesthesia, Infection, SR, American College of Emergency Physicians, Patient, Medical imaging

MAHWAH, N.J., Oct. 6, 2023 /PRNewswire-PRWeb/ -- Mindray, a global developer of healthcare technologies and solutions for ultrasound, patient monitoring, and anesthesia, announced today that they are exhibiting at the American College of Emergency Physicians (ACEP) 2023 Scientific Assembly at the Convention Center in Philadelphia, PA, October 9-12. They will highlight their latest advancements in Emergency Medicine, including the live debut of the TE Air Wireless Handheld Ultrasound System, the industry's first wireless transducer that connects to a fully-featured ultrasound system, the TE X, or independently with a mobile device. Mindray's newest point of care ultrasound (POCUS) system brings ultrasound to unprecedented heights, underscoring their dedication to the Emergency Medicine market and continuous innovation to drive the market forward. All ACEP attendees are invited to visit Booth 1226 to learn more about Mindray's innovative Emergency Medicine solutions.

Key Points: 
  • They will highlight their latest advancements in Emergency Medicine, including the live debut of the TE Air Wireless Handheld Ultrasound System , the industry's first wireless transducer that connects to a fully-featured ultrasound system, the TE X, or independently with a mobile device.
  • Mindray's newest point of care ultrasound (POCUS) system brings ultrasound to unprecedented heights, underscoring their dedication to the Emergency Medicine market and continuous innovation to drive the market forward.
  • Mindray introduces a groundbreaking 2-in-1 handheld ultrasound device with multi-device connectivity, the TE Air Wireless Handheld Ultrasound at ACEP23.
  • Mindray will feature live scanning with the TE X and TE Air Ultrasound in their booth throughout the show.

Radiology admins enthusiastic about new ultrasound systems

Retrieved on: 
Thursday, August 24, 2023
Hitachi, IMV, Mindray, Butterfly network, COVID-19, Radiology, GE, Samsung, Ultrasound, Hospital, FTE, Clarius, Philips, OEM, Medical imaging, Pharmaceutical industry, Online shopping, Science, Esaote, Fujifilm, Canon

ARLINGTON, Va., Aug. 24, 2023 /PRNewswire-PRWeb/ -- Radiology department administrators are enthusiastic about acquiring new ultrasound equipment over the next three years, driven by the anticipation that procedure volumes will shift from other imaging modalities to ultrasound, according to the recently published‥IMV 2023 Ultrasound Market Summary Report.

Key Points: 
  • ARLINGTON, Va., Aug. 24, 2023 /PRNewswire-PRWeb/ -- Radiology department administrators are enthusiastic about acquiring new ultrasound equipment over the next three years, driven by the anticipation that procedure volumes will shift from other imaging modalities to ultrasound, according to the recently published‥IMV 2023 Ultrasound Market Summary Report .
  • This enthusiasm for ultrasound persists despite a 2.3% decrease in overall number of general ultrasound patient exams, from 38.5‥million prior to the COVID-19 pandemic in 2019 to 37.6‥million in 2022.
  • In terms of individual general ultrasound systems, 85% of units owned and managed by radiology departments are cart-based, 11% are laptop/tablet, and 4% are handheld.
  • 95% of ultrasound exams are performed with cart-based systems, 5% with laptop/tablet systems, and less than 1% with handheld systems.

ADICON Holdings Limited One of the Top Three ICL Service Providers in China is Successfully Listed on Main Board of SEHK

Retrieved on: 
Friday, June 30, 2023
Carlyle, Mindray, ICL, Stock exchange, Motherboard, Growth, Seemabaddha

Morgan Stanley Asia Limited and Jefferies Hong Kong Limited are the Joint Sponsors, Overall Coordinators, Joint Global Coordinators, Joint Bookrunners and Joint Lead Managers.

Key Points: 
  • Morgan Stanley Asia Limited and Jefferies Hong Kong Limited are the Joint Sponsors, Overall Coordinators, Joint Global Coordinators, Joint Bookrunners and Joint Lead Managers.
  • ADICON has also entered into cornerstone investment agreements with investors including MR Global (HK) Limited (Mindray), Snibe Diagnostic (Hong Kong) Company Limited, Fosun Diagnostics (Shanghai) Co., Ltd., Timestar Elite Limited and Corelink.
  • Ms. YANG Ling, Chairwoman and Non-Executive Director of ADICON Holdings Limited, and Managing Director at Carlyle Asia, commented: "ADICON is one of the top three ICL service providers in China and an industry pioneer.
  • We believe the ICL market in China is still in a nascent stage and there remains significant room for the industry to grow.

ADICON Announces Proposed Listing on the Main Board of The Stock Exchange of Hong Kong at an Offer Price of HK$12.32 Per Share

Retrieved on: 
Monday, June 19, 2023
IPO, Mindray, Marketing, Stock exchange, Hematology, GH, Helmy Eltoukhy, Hospital, Cornerstone, Transport, Automation, Bruce High Quality Foundation, Atmosphere, NGS, Infection, Mass spectrometry, Motherboard, Laboratory, Knowledge, Growth, ChromeOS, ICL, COVID-19, SEHK, Flow cytometry, Nested polymerase chain reaction, Seemabaddha, Quality control, Carlyle, Partnership, CGP, University, EBITDA, Trust, Physician, City, Property management, Video game, Health insurance, Pharmaceutical industry, Warehouse, Fine chemical, Airline, Management, Audit, Medical device

-- ADICON will start its public offering in Hong Kong at 9:00 a.m. on Monday, 19 June 2023, and end at 12:00 noon on Friday, 23 June 2023.

Key Points: 
  • -- ADICON will start its public offering in Hong Kong at 9:00 a.m. on Monday, 19 June 2023, and end at 12:00 noon on Friday, 23 June 2023.
  • Dealings in shares on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") are expected to commence on Friday, 30 June 2023, with the stock code of 9860.HK, in board lots of 500 shares each.
  • -- Morgan Stanley Asia Limited and Jefferies Hong Kong Limited are the Joint Sponsors, Overall Coordinators, Joint Global Coordinators, Joint Bookrunners and Joint Lead Managers.
  • ADICON believes its quality assurance has positioned it strongly to broaden its customer base and capture an increasing market share.